Anaconda Biomed wins CE mark for funnel catheter

Anaconda Biomed announced today that it received CE mark approval to commercialize its ANA5 funnel catheter in Europe.

The company designed ANA5, a next-generation funnel catheter, to optimize mechanical thrombectomy. It maximizes clot capture with its vessel-matching diameter funnel. Simultaneously, it enables antegrade flow arrest and offers the potential for flow reversal to enhance aspiration-assisted clot retrieval. ANA5 promotes improved clot capture and removal through its unique proprietary geometry.

Barcelona, Spain-based Anaconda says it engineered the expandable and collapsible funnel catheter for interventional neurovascular procedures. ANA5 Advanced Neurovascular Access (ANA) features a radiopaque nitinol braid funnel. Covered with a polymeric coating, it enables local flow arrest.

Sign up for Blog Updates